Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)

The purpose of this phase III, open-label study is to determine the safety and tolerability of cyclosporine in the treatment of dry eye syndrome.

Inclusion Criteria:

• Diagnosis of dry eye syndrome

Exclusion Criteria:

• Intraocular or refractive surgery in the study eye within 3 months prior to study start
• Unwilling to discontinue use of contact lenses during the study
• Pregnancy or lactation